Menz Dirk-Henning, Feltgen Nicolas, Lechner Thorsten, Menz Helge, Müller Bernd-Kristof, Dresp Joachim, Hoerauf Hans
Pharmpur GmbH, Koenigsbrunn, Germany.
Department of Ophthalmology, University Medical Center, Goettingen, Germany.
Transl Vis Sci Technol. 2019 May 29;8(3):24. doi: 10.1167/tvst.8.3.24. eCollection 2019 May.
The complications with cytotoxic perfluorooctane (PFO) batches reported in 2015 were attributed to reactive underfluorinated impurities whose chemical identity and behavior still need to be clarified.
We analyzed original packaged samples of Alaocta batches involved in several reported cases of retinal toxicity. (A) The impurity profile was determined. (B) pH and fluoride ion content were measured. (C) Extraction with olive oil was performed to investigate differences in lipophilia among perfluorinated liquid (PFCL) as a measure for penetration of lipophilic cell membranes followed by measurements (A) and (B).
(A) The detected impurities can be divided into: (1) reactive underfluorinated compounds and their degradation products including hydrogen fluoride (HF), (2) nonreactive underfluorinated compounds, (3) surface active compounds, (4) nonreactive fluorinated compounds, and (5) leachables from primary packaging components. The highest acute toxic potential is associated with the impurities of group (1). (B) HF was detected as a degradation product of reactive underfluorinated impurities by relying on the pH values and fluoride ion content of the water extracts. (C) Lipophilic impurities dissolved in PFO migrate into lipophilic extraction medium. In particular, HF is rapidly transferred in this way.
HF as degradation product of unstable or reactive underfluorinated contaminants seems of particular importance triggering the acute toxicity of affected PFO. Contamination related toxicity and unwanted side effects can only be reliably excluded via analytical controlled multistage, high-purification processes.
In Alaocta batches different impurities show retinal toxicity. HF seems of particular importance of the acute toxicity of PFO.
2015年报告的细胞毒性全氟辛烷(PFO)批次的并发症归因于反应性欠氟化杂质,其化学特性和行为仍有待阐明。
我们分析了涉及几例视网膜毒性报告病例的Alaocta批次的原始包装样品。(A)确定杂质谱。(B)测量pH值和氟离子含量。(C)用橄榄油进行萃取,以研究全氟化液体(PFCL)之间亲脂性的差异,作为亲脂性细胞膜渗透的一种度量,随后进行测量(A)和(B)。
(A)检测到的杂质可分为:(1)反应性欠氟化化合物及其降解产物,包括氟化氢(HF),(2)非反应性欠氟化化合物,(3)表面活性化合物,(4)非反应性氟化化合物,以及(5)来自初级包装组件的可提取物。最高的急性毒性潜力与第(1)组杂质有关。(B)通过依靠水提取物的pH值和氟离子含量,检测到HF是反应性欠氟化杂质的降解产物。(C)溶解在PFO中的亲脂性杂质迁移到亲脂性萃取介质中。特别是,HF以这种方式迅速转移。
HF作为不稳定或反应性欠氟化污染物的降解产物,似乎对于引发受影响PFO 的急性毒性尤为重要。只有通过分析控制的多级高纯化过程,才能可靠地排除与污染相关的毒性和不良副作用。
在Alaocta批次中,不同杂质表现出视网膜毒性。HF似乎对于PFO的急性毒性尤为重要。